{"transactions":[{"id":737692,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T01:06:48.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":8423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2026."}],"balance_after":8423,"derivative":{"exercise_price":26.89,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":8423},"source":{"system":"sec-edgar","filing":"0001437749-26-020719","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1431872/000143774926020719/rdgdoc.xml","form_type":"4"}},{"id":737691,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T01:06:48.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on July 11, 2026."}],"balance_after":30000,"derivative":{"exercise_price":26.89,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-26-020719","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1431872/000143774926020719/rdgdoc.xml","form_type":"4"}},{"id":737690,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-15T21:04:07.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":11.6,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001610717-26-000219","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1431872/000161071726000219/form4.xml","form_type":"4"}},{"id":1061714,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-08-20T01:38:38.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 15, 2025."}],"balance_after":30000,"derivative":{"exercise_price":16.16,"expiration_date":"2035-08-15","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-25-027401","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1431872/000143774925027401/rdgdoc.xml","form_type":"4"}},{"id":1174638,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-09T21:26:56.000Z","date":"2025-04-08","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to one-third (1/3rd) of the shares subject to the option on each annual anniversary measured from April 8, 2025, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":2.82,"expiration_date":"2035-04-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001610717-25-000098","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1431872/000161071725000098/form4.xml","form_type":"4"}},{"id":1470578,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-06-24T23:38:10.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":11649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2024."}],"balance_after":11649,"derivative":{"exercise_price":14.55,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":11649},"source":{"system":"sec-edgar","filing":"0001437749-24-021129","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1431872/000143774924021129/rdgdoc.xml","form_type":"4"}},{"id":1470577,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-06-24T23:38:10.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on July 6, 2024."}],"balance_after":20000,"derivative":{"exercise_price":14.55,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-24-021129","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1431872/000143774924021129/rdgdoc.xml","form_type":"4"}},{"id":1865058,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-06-06T23:25:14.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":28487,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2023."}],"balance_after":28487,"derivative":{"exercise_price":5.95,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":28487},"source":{"system":"sec-edgar","filing":"0001437749-23-016801","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1431872/000143774923016801/rdgdoc.xml","form_type":"4"}},{"id":1865057,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-06-06T23:25:14.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on June 25, 2023."}],"balance_after":20000,"derivative":{"exercise_price":5.95,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-23-016801","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1431872/000143774923016801/rdgdoc.xml","form_type":"4"}},{"id":1885198,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-19T16:18:54.000Z","date":"2023-05-19","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested and were delivered to the Reporting Person on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested and were delivered to the Reporting Person on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service through such date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001169245-23-000033","document":"wf-form4_168452752005886.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924523000033/wf-form4_168452752005886.xml","form_type":"4"}},{"id":1885197,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T16:18:54.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001169245-23-000033","document":"wf-form4_168452752005886.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924523000033/wf-form4_168452752005886.xml","form_type":"4"}},{"id":2259896,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-24T00:54:02.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":79206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on August 19, 2022."}],"balance_after":79206,"derivative":{"exercise_price":2.14,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":79206},"source":{"system":"sec-edgar","filing":"0001104659-22-064005","document":"tm2216672-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1431872/000110465922064005/tm2216672-4_4seq1.xml","form_type":"4"}},{"id":2259895,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-24T00:54:02.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on June 19, 2022."}],"balance_after":20000,"derivative":{"exercise_price":2.14,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-22-064005","document":"tm2216672-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1431872/000110465922064005/tm2216672-4_4seq1.xml","form_type":"4"}},{"id":2262218,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-20T16:44:20.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest and be delivered to the Reporting Person on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest and be delivered to the Reporting Person on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date."}],"balance_after":3750,"derivative":{"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001169245-22-000060","document":"wf-form4_165307944363751.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924522000060/wf-form4_165307944363751.xml","form_type":"4"}},{"id":2262217,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2022-05-20T16:44:20.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date."}],"balance_after":17500,"derivative":{"exercise_price":0.8419,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001169245-22-000060","document":"wf-form4_165307944363751.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924522000060/wf-form4_165307944363751.xml","form_type":"4"}},{"id":2681308,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2021-06-04T18:17:25.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the 2022 annual meeting, subject to the reporting person's continuous service through each such date"}],"balance_after":14000,"derivative":{"exercise_price":3.53,"expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001169245-21-000065","document":"wf-form4_162284502821041.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000065/wf-form4_162284502821041.xml","form_type":"4"}},{"id":2700710,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-21T21:08:21.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":9069,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one year period, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":9069,"derivative":{"exercise_price":18.69,"exercise_date":"2021-09-05","expiration_date":"2031-05-20","underlying":"Common Stock","underlying_shares":9069},"source":{"system":"sec-edgar","filing":"0001209191-21-035012","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1431872/000120919121035012/doc4.xml","form_type":"4"}},{"id":2700709,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-21T21:08:21.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":20000,"derivative":{"exercise_price":18.69,"exercise_date":"2021-06-20","expiration_date":"2031-05-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-035012","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1431872/000120919121035012/doc4.xml","form_type":"4"}},{"id":3063349,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-08-10T15:39:58.000Z","date":"2020-08-06","kind":"grant","acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3) of the shares subject to the option will vest on August 6, 2021, and the remaining shares will vest in equal monthly installments thereafter over the following two year period, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":32500,"derivative":{"exercise_price":10.78,"exercise_date":"2021-08-06","expiration_date":"2030-08-06","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001209191-20-045891","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1431872/000120919120045891/doc4.xml","form_type":"4"}},{"id":3120776,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2020-06-05T18:58:48.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the 2021 annual meeting, subject to the reporting person's continuous service through each such date"}],"balance_after":16000,"derivative":{"exercise_price":4.86,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001169245-20-000065","document":"wf-form4_159139791077217.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000065/wf-form4_159139791077217.xml","form_type":"4"}},{"id":3530106,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2019-05-13T16:38:20.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the date of the 2020 annual meeting, subject to the reporting person's continuous service through each such date"}],"balance_after":2750,"derivative":{"exercise_price":13.23,"expiration_date":"2029-05-09","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0001209191-19-029357","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000120919119029357/doc4.xml","form_type":"4"}},{"id":3623536,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2019-03-01T17:03:46.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in equal monthly installments over 36 months from February 27, 2019, subject to the reporting person's continued service through each such date."}],"balance_after":23000,"derivative":{"exercise_price":3.15,"expiration_date":"2029-02-27","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001209191-19-015085","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000120919119015085/doc4.xml","form_type":"4"}},{"id":3623535,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2019-03-01T17:03:46.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in equal monthly installments over 36 months from February 27, 2019, subject to the reporting person's continued service through each such date."}],"balance_after":22000,"derivative":{"exercise_price":3.15,"expiration_date":"2029-02-27","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-19-015085","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000120919119015085/doc4.xml","form_type":"4"}}]}